Article
DNA testing for haemochromatosis: diagnostic, predictive and screening implications.
Pathology - 1 Nov 2000
Trent R J, Le H, Yu B, Young G, Bowden D K
Abstract excerpt
Since 1996, the identification of the HFE gene has enabled DNA testing for hereditary haemochromatosis (HH). The range of DNA testing available includes: (1) diagnostic, (2) predictive (also called presymptomatic testing) and (3) screening. Access to DNA testing has been facilitated by an Australian Medicare rebate, the first available for genetic disorders. Despite the availability of HFE DNA testing in HH, it...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
